NicholasLoweMD

PubMed

• 4 citations
  Nonnucleoside Reverse Transcriptase Inhibitor-Resistant HIV Is Stimulated by Efavirenz during Early Stages of Infection
  Jiong Wang, Gang Zhang, Robert A. Bambara, Dongge Li, Hua Liang, Hulin Wu, Hannah M. Smith, Nicholas Lowe, Lisa M. Demeter, Carrie Dykes> ;Journal of Virology. 2011 Oct 15
• 97 citations
  Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and saf...
  Nicholas J. Lowe, Dee Anna Glaser, Nina Eadie, Simon Daggett, Jonathan W. Kowalski, Pan-Yu Lai> ;Journal of the American Academy of Dermatology. 2007 Apr 1
• 66 citations
  The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
  Nicholas J. Lowe, A. Campanati, I. Bodokh, S. Cliff, P. Jaen, O. Kreyden, Markus Naumann, A. Offidani, J. Vadoud, H. Hamm> ;The British Journal of Dermatology. 2004 Dec 1
• 258 citations
  Recognition, diagnosis, and treatment of primary focal hyperhidrosis
  John Hornberger, Kevin Grimes, Markus Naumann, Dee Anna Glaser, Nicholas J. Lowe, Hans Naver, Samuel Ahn, Lewis P Stolman> ;Journal of the American Academy of Dermatology. 2004 Aug 1
• 213 citations
  Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial
  Markus Naumann, Nicholas J. Lowe> ;BMJ. 2001 Sep 15
• 50 citations
  The safety of etretinate as long-term therapy for psoriasis: Results of the Etretinate Follow-up Study
  Robert S. Stern, Elizabeth Fitzgerald, Charles N. Ellis, Nicholas J. Lowe, Michael T. Goldfarb, Richard D. Baughman> ;Journal of the American Academy of Dermatology. 1995 Jul 1
• 26 citations
  Photoreactions with a fluoroquinolone antimicrobial: evening versus morning dosing.
  Nicholas J. Lowe, T Daniel Fakouhi, Robert S. Stern, Teresa Bourget, Barbara Roniker, Edward Allen Swabb> ;Clinical Pharmacology and Therapeutics. 1994 Nov 1
• 10 citations
  A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses
  Cynthia Guzzo, Jonathan S. Weiss, Herman S. Mogavero, Charles N. Ellis, Nardo Zaias, Nicholas J. Lowe, Francisco A. Kerdel, James Milbauer, Jeffrey D. Bernhard, Claire...> ;Journal of the American Academy of Dermatology. 1991 Dec 1
• 15 citations
  Serum 8-methoxypsoralen (8-MOP) concentrations after bath water delivery of 8-MOP plus UVA.
  Michael David, Nicholas J. Lowe, Rebat M. Halder, Michael Borok> ;Journal of the American Academy of Dermatology. 1990 Nov 1
• 23 citations
  Effects of 13-cis retinoic acid therapy on human antibody responses to defined protein antigens.
  Neil Sidell, Michael J. Connor, Bieshia Chang, Nicholas J. Lowe, Michael Borok> ;The Journal of Investigative Dermatology. 1990 Nov 1
• 6 citations
  Sunscreens and the Prevention of Skin Aging
  Nicholas J. Lowe> ;The Journal of Dermatologic Surgery and Oncology. 1990 Oct 1
• 27 citations
  Psoriasis therapy: comparative studies with a hydrocolloid dressing, plastic film occlusion, and triamcinolone acetonide cream.
  Michael David, Nicholas J. Lowe> ;Journal of the American Academy of Dermatology. 1989 Sep 1
• 10 citations
  Extensive spinal hyperostosis in a patient receiving isotretinoin--progression after 4 years of etretinate therapy.
  C.B. Archer, P. M. Elias, Nicholas J. Lowe, W.A.D. Griffiths> ;Clinical and Experimental Dermatology. 1989 Jul 1
• 3 citations
  Erythema multiforme-like eruptions associated with etretinate therapy.
  M. David, M. Sandbank, Nicholas J. Lowe> ;Clinical and Experimental Dermatology. 1989 May 1
• 2 citations
  Newer retinoids for psoriasis—Early clinical studies
  L. Matt, V.N. Lazarus, Nicholas J. Lowe> ;Pharmacology & Therapeutics. 1989 Jan 1
• 21 citations
  New retinoids for dermatologic diseases. Uses and toxicity.
  Nicholas J. Lowe, Michael David> ;Dermatologic Clinics. 1988 Oct 1
• 11 citations
  Sunscreens and phototesting
  Nicholas J. Lowe, Daniel P. Weingarten, Mitchell S. Wortzman> ;Clinics in Dermatology. 1988 Jul 1
• 27 citations
  Systemic retinoid therapy for psoriasis.
  Nicholas J. Lowe, Veronica Lazarus, Lawrence H. Matt> ;Journal of the American Academy of Dermatology. 1988 Jul 1
• 3 citations
  Etretinate. Appropriate use in severe psoriasis.
  Nicholas J. Lowe, John J. Voorhees> ;Archives of Dermatology. 1988 Apr 1
• 1 citations
  Effect of forskolin on beta-adrenergic hyporesponsiveness in skin.
  G. W. De Vries, Lawrence D. Amdahl, Nicholas J. Lowe, Larry A. Wheeler> ;Skin Pharmacology. 1988 Jan 1
• 15 citations
  Actinic reticuloid in a black man: Successful therapy with azathioprine
  Timothy P. Kingston, Nicholas J. Lowe, Howard Sofen, Daniel P. Weingarten> ;Journal of the American Academy of Dermatology. 1987 May 1
• 4 citations
  Comparative efficacy of two dosage forms of oral methoxsalen in psoralens plus ultraviolet A therapy of psoriasis
  Nicholas J. Lowe, Frederick Urbach, Philip L. Bailin, Daniel P. Weingarten> ;Journal of the American Academy of Dermatology. 1987 May 1
• 23 citations
  Visual and cutaneous toxicity which occurs during N-(4-hydroxyphenyl) retinamide therapy for psoriasis.
  T.P. Kingston, Nicholas J. Lowe, J. Winston, J. Heckenlively> ;Clinical and Experimental Dermatology. 1986 Nov 1
• 30 citations
  Depletion of Cutaneous Glutathione and the Induction of Inflammation by 8-Methoxypsoralen Plus UVA Radiation
  Larry A. Wheeler, Angelika Aswad, Michael J. Connor, Nicholas J. Lowe> ;The Journal of Investigative Dermatology. 1986 Nov 1
• 18 citations
  Differential rates of percutaneous absorption through the eczematous and normal skin of a monkey
  Robert L. Bronaugh, Daniel P. Weingarten, Nicholas J. Lowe> ;The Journal of Investigative Dermatology. 1986 Oct 1
• Join now to see all